New research deepens Havana Syndrome mystery
The mystery of so-called Havana Syndrome, which struck down dozens of US diplomats, deepened Monday as new research found no tangible evidence of brain injury in those affected. Researchers at the National Institutes of Health (NIH) acknowledged that ongoing symptoms including migraines, chronic dizziness, and depression are still very much real—even if they cannot yet be explained.
Havana Syndrome first baffled officials in 2016 when US diplomats in Cuba’s capital reported falling ill and hearing piercing sounds at night, sparking speculation of an attack by a foreign enemy using an unspecified sonar weapon. Similar reports of the illness later emerged from embassy staff in China, Europe and US capital Washington.
Yet despite the “disabling” symptoms, people with Havana Syndrome—formally referred to as anomalous health incidents (AHIs) -- show no clinical differences, according to two new papers published Monday in peer-reviewed journal JAMA.
Leighton Chan, lead author of one of the papers, said “it’s important to acknowledge that these symptoms are very real, cause significant disruption in the lives of those affected and can be quite prolonged, disabling and difficult to treat.” In this study, researchers assessed more than 80 US government officials and their family members using MRI brain scans and other blood, visual and auditory tests. They were compared with a control group of overseas US officials who had similar work assignments but were unaffected by the symptoms. It found those with AHIs self-reported increased symptoms of fatigue, post-traumatic stress and depression.
Forty one percent of those with AHIs met the criteria for “functional neurological disorder”— problems with the way the brain sends and receives information from the rest of the body, and as a result nearly all with this dysfunction could be diagnosed with a chronic form of dizziness. “These individuals have symptoms that are genuine, distressing, and can be quite prolonged, disabling, and difficult to treat,” said the researchers.
In the second paper, participants underwent MRI scans to examine their brain size, structure, and function. These were carried out on average 80 days after symptom onset and revealed no imaging abnormalities differentiating the group with AHIs. But this “does not exclude that an adverse event impacting the brain occurred at the time of the AHI,” said Carlo Pierpaoli, who led the study. — AFP